Premium
Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia
Author(s) -
Chang Hung,
Kuo MingChung,
Lin TungLiang,
Wu JinHou,
Wang PoNan
Publication year - 2018
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.13668
Subject(s) - medicine , incidence (geometry) , myeloid leukaemia , pneumocystis jirovecii , pneumonia , pediatrics , myeloid , pneumocystis carinii , pneumocystis pneumonia , physics , optics
The association of Pneumocystis jirovecii pneumonia (PJP) and acute myeloid leukaemia (AML) is not clearly defined. In our experience of 291 patients with AML, 20 (14 males and 6 females, median age 56) developed PJP (incidence 6.8%). Thirteen patients (65%) survived until discharge from hospital. We conclude that PJP is not uncommon among patients with AML. In clinical care of AML, awareness of PJP should be heightened and prophylaxis should be considered.